Manufacturers Face Challenges and Regulatory Changes

November 2, 2001
Jill Wechsler
Jill Wechsler

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Pharmaceutical Technology, Pharmaceutical Technology-11-02-2001, Volume 25, Issue 11

Threats of bioterrorism generate new reulatory policies to protect the public against biological warfare.

Related Content:

Regulatory Watch